The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)
306.80
-1.80 (-0.58%)
At close: Dec 4, 2025
DSE:IBNSINA Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 3, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Market Capitalization | 9,586 | 9,189 | 7,805 | 8,954 | 9,270 | 7,708 | Upgrade
|
| Market Cap Growth | 1.66% | 17.73% | -12.84% | -3.40% | 20.27% | 10.08% | Upgrade
|
| Enterprise Value | 11,454 | 10,667 | 8,919 | 9,692 | 9,892 | 8,398 | Upgrade
|
| Last Close Price | 306.80 | 287.80 | 239.44 | 268.97 | 272.99 | 223.17 | Upgrade
|
| PE Ratio | 12.45 | 14.51 | 11.64 | 14.79 | 15.30 | 15.76 | Upgrade
|
| PS Ratio | 0.75 | 0.77 | 0.69 | 0.98 | 1.09 | 1.05 | Upgrade
|
| PB Ratio | 2.27 | 2.30 | 2.21 | 2.93 | 3.53 | 3.59 | Upgrade
|
| P/TBV Ratio | 2.31 | 2.34 | 2.23 | 2.96 | 3.56 | 3.59 | Upgrade
|
| P/FCF Ratio | - | - | - | 18.93 | 173.59 | 24.89 | Upgrade
|
| P/OCF Ratio | 16.22 | 12.70 | 20.02 | 9.97 | 22.15 | 13.96 | Upgrade
|
| EV/Sales Ratio | 0.89 | 0.90 | 0.78 | 1.06 | 1.17 | 1.14 | Upgrade
|
| EV/EBITDA Ratio | 9.02 | 9.81 | 8.16 | 6.22 | 9.69 | 9.11 | Upgrade
|
| EV/EBIT Ratio | 10.75 | 11.82 | 9.75 | 11.82 | 12.05 | 11.46 | Upgrade
|
| EV/FCF Ratio | -25.51 | - | - | 20.49 | 185.25 | 27.12 | Upgrade
|
| Debt / Equity Ratio | 0.52 | 0.52 | 0.53 | 0.32 | 0.41 | 0.40 | Upgrade
|
| Debt / EBITDA Ratio | 1.71 | 1.86 | 1.69 | 0.62 | 1.02 | 0.91 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 2.09 | 20.02 | 2.80 | Upgrade
|
| Asset Turnover | 1.80 | 1.69 | 1.98 | 1.96 | 2.08 | 2.03 | Upgrade
|
| Inventory Turnover | 4.62 | 4.18 | 4.99 | 4.86 | 5.49 | 6.00 | Upgrade
|
| Quick Ratio | 0.22 | 0.22 | 0.32 | 0.23 | 0.35 | 0.27 | Upgrade
|
| Current Ratio | 1.16 | 1.15 | 1.13 | 1.26 | 1.46 | 1.26 | Upgrade
|
| Return on Equity (ROE) | 19.63% | 16.82% | 20.38% | 21.33% | 25.37% | 24.91% | Upgrade
|
| Return on Assets (ROA) | 9.31% | 8.02% | 9.93% | 11.00% | 12.59% | 12.58% | Upgrade
|
| Return on Capital (ROIC) | 11.42% | 9.82% | 12.08% | 13.24% | 15.30% | 15.90% | Upgrade
|
| Return on Capital Employed (ROCE) | 20.10% | 17.80% | 21.80% | 23.10% | 25.80% | 27.20% | Upgrade
|
| Earnings Yield | 8.03% | 6.89% | 8.59% | 6.76% | 6.54% | 6.35% | Upgrade
|
| FCF Yield | -4.68% | -2.81% | -7.13% | 5.28% | 0.58% | 4.02% | Upgrade
|
| Dividend Yield | 2.09% | 2.22% | 2.63% | 2.23% | 2.20% | 2.11% | Upgrade
|
| Payout Ratio | 25.34% | 30.62% | 26.83% | 29.49% | 29.28% | 26.89% | Upgrade
|
| Total Shareholder Return | 2.09% | 2.22% | 2.63% | 2.23% | 2.20% | 2.11% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.